These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8092841)
1. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction. Ko YT; Ludescher RD; Frost DJ; Wasserman BP Antimicrob Agents Chemother; 1994 Jun; 38(6):1378-85. PubMed ID: 8092841 [TBL] [Abstract][Full Text] [Related]
2. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans. Angiolella L; Simonetti N; Cassone A J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807 [TBL] [Abstract][Full Text] [Related]
3. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy. Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115 [TBL] [Abstract][Full Text] [Related]
5. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans. Angiolella L; Bromuro C; Simonetti N; Cassone A J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538 [TBL] [Abstract][Full Text] [Related]
6. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase. Tang J; Parr TR Antimicrob Agents Chemother; 1991 Jan; 35(1):99-103. PubMed ID: 1826595 [TBL] [Abstract][Full Text] [Related]
8. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections. Rennie RP; Hellman L Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726 [TBL] [Abstract][Full Text] [Related]
9. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis. Hall GS; Myles C; Pratt KJ; Washington JA Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin. Richardson MD; Smyth LA; Shankland GS FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051 [TBL] [Abstract][Full Text] [Related]
11. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils. Richardson MD; Scott G; Shankland GS Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379 [TBL] [Abstract][Full Text] [Related]
12. Cilofungin inhibition of (1-3)-beta-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity. Taft CS; Selitrennikoff CP J Antibiot (Tokyo); 1990 Apr; 43(4):433-7. PubMed ID: 2141016 [No Abstract] [Full Text] [Related]
13. The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans. Angiolella L; Facchin M; Simonetti N; Cassone A J Chemother; 1995 Apr; 7(2):83-9. PubMed ID: 7666125 [TBL] [Abstract][Full Text] [Related]
14. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. Meshulam T; Levitz SM; Diamond RD; Sugar AM J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424 [TBL] [Abstract][Full Text] [Related]
15. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans. Pfaller M; Riley J; Koerner T Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329 [TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847 [TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species. Smith KR; Lank KM; Dismukes WE; Cobbs CG Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435 [TBL] [Abstract][Full Text] [Related]
18. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis. Walsh TJ; Lee JW; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo PA Antimicrob Agents Chemother; 1991 Jul; 35(7):1321-8. PubMed ID: 1929288 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B. Meunier F; Lambert C; Van der Auwera P J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118 [TBL] [Abstract][Full Text] [Related]
20. Emodin Reduces the Activity of (1,3)- Janeczko M Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]